期刊文献+

血脂康普伐他汀降低老年人胆固醇疗效比较

A Comparison on the Effect of Xuezhikang and Pravastatin on Lowering Cholesterol for the Old
下载PDF
导出
摘要 目的:评价血脂康与普伐他汀对高脂血症的疗效。方法:155例高脂血症病人随机分为2组,血脂康组75例,年龄(60±9)岁,采用血脂康丸2粒(每粒0.3g),po,bid,疗程为8周。普伐他汀组80例,年龄(60±9)岁,采用普伐他汀20mg,晚餐后顿服,疗程为8周。结果:2组治疗后血清总胆固醇数值下降,血脂康组有效率为90.66%;普伐他汀组有效率为92.5%。两组经χ2检验比较,无统计学意义,疗效相近。结论:血脂康与普伐他汀疗效相似,均为安全、有效的降脂药物,血脂康优点为价廉。 Objective. To evaluate the effect of Xuezhikang and Pravastatin on hyperlipidemia. Methods. Randomly divide 155 patients with hyperlipidemia into 2 groups, 75 cases for Xuezhikang group, in this group, the range of age was 60± 9,all the patients orally took 2 Xuezhikang tablets twice a day (each Tablet weighed 0.3g), the course of the treatment was 8 weeks. As for the 80 cases in pravastatin,the range of age was 60±9, they were treated with pravastatin, it was administered at draught, the course of the treatment was 8 weeks. Results.The value of the overall cholesterol in serum declined in both Group after treatment, the effect rate in Xuezhikang group was 90.66%,while the figure was 92.5% in pravastatin group,after the Z2 test and comparison between the 2 groups,it was found not statistically significant, the effect in the 2 groups were nearly the same. Conclusion: The effect of Xuezhikang and Pravastatin are similar, Both of them are safe and can effectively lower cholesterol. Xuezhikang Features with cheap price.
作者 卢斌
出处 《数理医药学杂志》 2015年第7期1038-1039,共2页 Journal of Mathematical Medicine
关键词 血脂康 普伐他汀 高脂血症 xuezhikang pravastatin hyperlipidemia
  • 相关文献

参考文献7

二级参考文献12

  • 1朱燕,李长龄,王银叶.血脂康对高脂家兔、鹌鹑模型的降脂作用[J].中国药学杂志,1995,30(11):656-660. 被引量:83
  • 2Heart protection study collaborative Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals:a randomized placebo-controlled trial. Lancet ,2002:360:7-22.
  • 3Perdersen TR. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease :the Scandinavian simvastatin Survival Study (4S). Lancet ,1994,344:1383-1389.
  • 4Expert panel on Detection. Evaluation and Treatment of High Blood cholesterol in Adults. Excutive Summary of the Third Report of the National cholesterol Education Program(NCEP) Expert pane/on Detection,Evaluation,and Treatment of High Blood cholesterol i
  • 5Aronow HD, Topol EJ, Roe MT, et al. Effect of lipid-lowing therapy on early mortality after acute coronary syndromes: an observational study. Lancet, 2001, 357 :1063-1068.
  • 6Waters DD, Early pharmacologic intervention and plague stability in acute coronary syndrome. Am J Cardial, 2001, 88(8A): 30k-36k.
  • 7Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress[ J ]. Circulation, 2000,102 ( suppl 4) ; 14.
  • 8Bristow MR. Beta 2 adrenergic receptor blockade in chromic heart failure[ J ]. Circulation, 2000,101(5) : 558.
  • 9Ruffolo RR, Feuerstein GI. Neurohorrnonal activation, oxygen flee radicals, and apoptosis in the pathogenesie of congestive heart failure [J] .J Cardiovase Pharmacol, 1998, 32(suppl 1) :S22.
  • 10Sackner-Bernstein JD. Use of carvedilol in chronic heart failure: challenges in therapeutic management prog [ J ]. Cardiovasc Dis, 1998, 41 (suppl 1) : S 53.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部